Quick Answer
bioAffinity Technologies, Inc. reported Shares Outstanding of 4.50 million shares for fiscal year 2025.
bioAffinity Technologies, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.50M | +766.5% |
| 2024 | 519,158 | -94.5% |
| 2023 | 9.39M | +12.1% |
| 2022 | 8.38M | +213.1% |
| 2021 | 2.68M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.47M | -74.2% | -87.8% |
| June 30, 2025 | 28.46M | +147.8% | +55.9% |
| March 31, 2025 | 18.26M | +62.8% | +3497.1% |
| December 31, 2024 | 507,520 | -94.6% | -96.2% |
| September 30, 2024 | 13.42M | +45.7% | +16.9% |
| June 30, 2024 | 11.49M | +34.3% | +2.4% |
| March 31, 2024 | 11.22M | +32.5% | +19.4% |
| December 31, 2023 | 9.39M | +12.1% | +1.9% |
- bioAffinity Technologies, Inc. showed an increase of +766.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, bioAffinity Technologies, Inc.’s shares outstanding has grown by 68.0% (from 2.68 million shares to 4.50 million shares).
- The most recent figure is from bioAffinity Technologies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: